Benitec Announces Launch of DNA-Delivered RNAi Products for Research Applications by Promega
QUEENSLAND, Australia. Benitec Ltd announced the launch of siSTRIKE(TM) vectors, a new line of gene silencing products that mediate RNA interference using Benitec's proprietary DNA-directed RNA interference (ddRNAi) technology. Developed by Promega Corporation of Madison, Wisconsin, siSTRIKE vectors are the first products to emerge from the world-wide exclusive licensing agreement between Benitec and Promega announced April 8, 2003.
"ddRNAi is being widely recognized as the most efficient and precise method of triggering RNA interference. With the siSTRIKE line of products and Promega's global expertise and marketing capabilities, we are confident that ddRNAi will continue to gain recognition as the gene silencing technology of choice for research applications. Promega's ddRNAi product range and revenues from sales will continue to increase during the current year and will be supplemented by new Chemicon ddRNAi products, following the recently announced Chemicon sub-licence deal," said John McKinley, Chairman and Chief Executive Officer of Benitec Limited.
"siSTRIKE vectors from Promega will provide the quality and dependability required by researchers to effectively apply Benitec's proprietary ddRNAi gene silencing technology in their laboratories," continued McKinley.
Other news from the department business & finance
These products might interest you
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
